[Inflammation and ischaemic stroke: current status and future perspectives]. (Q54707697)

3 June 2018

review article

1 reference

title

[Inflammation and ischaemic stroke: current status and future perspectives]. (English)

1 reference

3 June 2018

0 references

Y Samson

1

1 reference

3 June 2018

B Lapergue

series ordinal

2

1 reference

3 June 2018

H Hosseini

series ordinal

3

1 reference

3 June 2018

language of work or name

French

0 references

publication date

1 December 2005

1 reference

3 June 2018

published in

Revue neurologique

1 reference

3 June 2018

volume

161

1 reference

3 June 2018

issue

12 Pt 1

1 reference

3 June 2018

page(s)

1177-1182

1 reference

3 June 2018

Inflammation and acute stroke

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Stroke severity determines body temperature in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Inflammatory mechanisms after ischemia and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Is insulin an antiinflammatory molecule?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Association between blood pressure and C-reactive protein levels in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Angiotensin-Converting Enzyme Inhibitor Use Is Associated With Reduced Plasma Concentration of C-Reactive Protein in Patients With First-Ever Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Locking a leukocyte integrin with statins

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Inflammatory cell adhesion molecules in ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Cerebral ischemia and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Mechanisms, challenges and opportunities in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Therapeutic hypothermia for acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Neuroprotective properties of statins in cerebral ischemia and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2805%2985190-2

7 January 2021

10.1016/S0035-3787(05)85190-2

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

16340912

1 reference

3 June 2018